Skip to Content

Ansell Ltd ANN

Morningstar Rating
A$25.30 −0.14 (0.55%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Corporate Action: We Recommend Participating in Ansell’s Raise Subject to Individual’s Goals

Ansell is acquiring Kimberly-Clark’s Personal Protective Equipment business, or KCPPE, for USD 640 million. We think Ansell is paying a good price and is getting the business for less than we think it’s worth. We increase our fair value estimate by 7% to AUD 32 as we assume stronger returns on new capital that Ansell invests in the future. We think this is appropriate given that KCPPE is a higher-margin business and is significantly less capital-intensive. While we think Ansell is getting a good price, the accompanying dilutive equity raise at AUD 22.45 per share partially offsets the benefit to fair value. Assuming the raise is fully subscribed, it adds 21 million shares, a 17% expansion of the share count.

Price vs Fair Value

ANN is trading at a 20% discount.
Price
A$25.44
Fair Value
A$49.00
Uncertainty
Medium
1-Star Price
A$93.60
5-Star Price
A$19.90
Economic Moat
Nxygsm
Capital Allocation
Ydvxvjwnr

Bulls Say, Bears Say

Bulls

The fruits of Ansell’s restructuring efforts, being improved organic growth and expanding margins, started to become evident prepandemic in the first half of fiscal 2020.

Bears

Cost pressures, as well as manufacturing and supply chain disruptions are lingering with the threat of continued surges in covid-19.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
A$25.44
Day Range
A$24.8725.38
52-Week Range
A$21.0027.91
Bid/Ask
A$24.81 / A$25.44
Market Cap
A$3.61 Bil
Volume/Avg
363,941 / 433,640

Key Statistics

Price/Earnings (Normalized)
21.36
Price/Sales
1.33
Dividend Yield (Trailing)
2.59%
Dividend Yield (Forward)
2.59%
Total Yield
4.12%

Company Profile

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
46,758

Competitors

Valuation

Metric
ANN
RKT
CHD
Price/Earnings (Normalized)
21.369.6133.65
Price/Book Value
1.383.686.71
Price/Sales
1.332.144.49
Price/Cash Flow
9.8011.5725.31
Price/Earnings
ANN
RKT
CHD

Financial Strength

Metric
ANN
RKT
CHD
Quick Ratio
0.860.400.61
Current Ratio
2.110.641.08
Interest Coverage
7.379.009.72
Quick Ratio
ANN
RKT
CHD

Profitability

Metric
ANN
RKT
CHD
Return on Assets (Normalized)
4.13%8.60%9.58%
Return on Equity (Normalized)
6.66%26.61%21.40%
Return on Invested Capital (Normalized)
5.67%14.24%14.37%
Return on Assets
ANN
RKT
CHD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncZzbggvdtJpc$133.1 Bil
BDX
Becton Dickinson & CoTlcbrmkZjtfb$66.9 Bil
ALC
Alcon IncCwbddrqdYnvrbl$38.9 Bil
RMD
ResMed IncHnsfnvcpgFtkdmqm$32.1 Bil
CLPBY
Coloplast A/S ADRLqmhvlmxgMxx$27.9 Bil
WST
West Pharmaceutical Services IncPcmjrhrmkCpq$26.4 Bil
BAX
Baxter International IncBlqjygnrcHnrbn$20.4 Bil
HOLX
Hologic IncGpgkwspgkZxqkvwz$17.8 Bil
COO
The Cooper Companies IncTmqnzfklgZwddjp$17.7 Bil
TFX
Teleflex IncTnlqyZkk$9.7 Bil

Sponsor Center